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SUMMARY
The genetic variation in mtDNA has been widely used to give a maternal genetic
perspective of the human demographic history. Here, we have studied this
variability in 686 samples coming from the Centre and North of Spain. These
results showed that haplogroup frequencies were similar to other Spanish studies
and European populations. Haplogroups from the HV lineage were over-represented
in the Spanish population. A deeper analysis of the mitochondrial haplogroup U
showed differences with Northern Europe populations. The frequencies of
haplogroups found give them high valour when experimental design for
mitochondrial disorder studies in population is planted. In addition, the use of
these data is also important for forensic studies.
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RESUMEN
Distribución de líneas mitocondriales en la población española:
anticipándonos a los estudios de asociación
La variación genética en el mtDNA ha sido ampliamente utilizada para dar una
perspectiva de la historia demográfica humana. En este estudio, nosotros hemos
analizado esta variabilidad en 686 muestras del Centro y Norte de España. La fre-
cuencia de los haplogrupos en la población española es muy similar a la observada
en otros estudios sobre esta población y a las frecuencias en las poblaciones euro-
peas. Un análisis más profundo del haplogrupo mitocondrial U mostró diferencias
con las poblaciones del norte de Europa. El conocimiento de la distribución de fre-
cuencias de los haplogrupos en nuestra población supone un resultado importante
para el diseño de estudios sobre enfemedades mitocondriales. Además, nuestros
resultados son también importantes en los estudios forenses.
Palabras clave: DNA mitocondrial.—Humanos.—Variabilidad.—Haplogrupos.—
Fosforilación oxidativa.
INTRODUCTION
In 1997, different laboratories published an association between
the mitochondrial genetic background and the Leber’s Hereditary
Optic Neuropathy (LHON) in patients with any of two different
pathologic mutations, 11778A and 14484C (1-4). Mitochondrial
haplogroup J was overrepresented in patients with any of these
mutations and it was postulated that this haplogroup increased the
penetrance of the pathologic mutation. Since then, other haplogroups
have been associated with different phenotypes (5, 6), particularly
with aging (7-10) and aging-related diseases, such as Parkinson
disease (11-13) and Alzheimer disease (14, 15).
A mitochondrial haplogroup is a cluster of phylogenetically
related mitochondrial genotypes (haplotypes). These haplogroups are
defined by ancient mutations. These changes appeared and survived,
therefore, they could not be deleterious mutations. Most of them
probably had not phenotypic effect and they were neutral. Some of
them had a beneficent effect and were positively selected. However,
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this positive effect was related with a particular environment and
nowadays, in other environmental conditions, they may have
different effects on the phenotype (16-18).
Several major haplogroups (H, V, J, T, U, I, W, X) were described
in Western Eurasian individuals (19) and their frequencies were
very similar all around Europe (20). The increased interest in
mitochondrial population genetics has made possible to subdivide
these haplogroups in smaller clusters, called subhaplogroups. The
frequency and distribution of these subhaplogroups is not the same
in different European populations (6, 21-23). Similarly to the
haplogroups, some of the mutations defining these subhaplogroups
might have a phenotypic effect and then, they could contribute to
the distinct prevalence of these diseases in different populations (24).
In advance of next epidemiologic studies in the Spanish
population trying to associate phenotypes to mitochondrial genetic
background, we decided to characterize the Spanish population
according to the mitochondrial haplogroups.
MATERIAL AND METHODS
Peripheral blood was collected from 686 unrelated individuals
from Northern and Centre of Spain (Zaragoza and Madrid).
Genomic DNA was extracted by conventional methods (25) and
the samples were haplogrouped by PCR amplification of short
mtDNA fragments, followed by restriction enzyme analysis (RFLP
analysis). We used the haplogrouping strategy from (5) (Table 1).
Hypervariable region I (HVR-I) was sequenced in order to confirm
haplogroups and determine subhaplogroups U. Full description of
oligodeoxynucleotides utilized and PCR amplification conditions are
available upon request.
Results and differences in diverse mitochondrial variants among
populations were assessed by the Chi square independence test from
contingency tables and post hoc analysis. Significant differences were
assumed when P ≤ 0.05.
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TABLE 1. RFLP polymorphisms used for mtDNA Haplogroups determination.
Individuals of non-European origin as haplogroups L (African), M (Asian) and
those that we could not ascribe to any of the known Caucasian haplogroups were
grouped as others (O) as it has been previously reported (5).
* Indicate non synonymous polymorphism
Characteristic restriction site(s) Hipervariable
Haplogroups
Coding-region mutations Region I
- T14766C* MseI, Tru9I
H
- T7028C AluI
- T14766C* MseI, Tru9I
V T16298C
- G4580A NlaIII
HV* - T14766C* MseI, Tru9I
+ T4216C* Afl III
J C16069T-T16126C
- G13708A* Mva I
+ T4216C* Afl III
T T16126C-C16294T
+ A4917G* Mae I
U + A12308G Hinf I
- A4529T Hae II
G16129C-C16223T
I
G16391A
W - G8994A Hae III C16223T-C16292T
T16189C-C16223T
X + T14470A Acc I
C16278T
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RESULTS
The analysis of 686 Spaniard individuals from North and center
of Spain gave us a picture of the haplogroup frequencies in the
Spanish population (Table 2). Then, we compared our results with
those from a collection of 718 Spaniard samples from the literature
coming from the whole country (Table 2). The individual haplogroup
frequencies were very similar, although we found significant
differences (χ = 29.8, df = 9, P < 0.001). These differences were due
to an excess of HV* [P (post-hoc cell contribution-phcc) < 0.001] and
a defect of W [P (phcc) = 0.009] individuals in our samples versus
the other studies {HV*, [P (phcc ) < 0.001]; W, [P (phcc) = 0.012]}.
However, there was no difference in the major haplogroups. As we
were interested in the haplogroup distribution in the whole country
because epidemiologic studies require large populations and because
the differences were only found in minor haplogroups, we decided
to combine all the individuals in a big Spanish sample (1404
individuals).
Next, we compared the whole Spanish sample with a collection
of 2648 European individuals from the literature (Table 2). We found
significant differences in the haplogroup distribution (χ = 136.0, df
= 9, P < 0.001). H, V and HV* were overrepresented in the Spanish
population but T, I, and O lineages were underrepresented [P (phcc)
≤ 0.009, for all of them]. The opposite tendency was found in the
European samples [P (phcc) ≤ 0.001, for H, HV*, I and O].
Mitochondrial haplogroup U is an ancient cluster widely
distributed in Western Eurasian and very well genetically defined.
Therefore, we subdivided our 155 U samples in subhaplogroups and
compared them to 1802 U European (6) and 455 Italian individuals
(24) (Table 3). Despite some classification problems, we were able to
confirm the previously observed tendency in the subhaplogroups U
distribution. Those subhaplogroups defined by changes in very well
evolutionary conserved positions in the cytochrome b were
overrepresented in northern latitudes, the rest were prevalent in
southern latitudes (Table 3). An exception was mitochondrial
subhaplogroup K. Its prevalence was clearly higher in the South in
both Spanish and Italian populations.
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TABLE 2. Mitochondrial haplogroups distribution (number of individuals and
percentages values between bracket) in North and Centre of Spain. The results
obtained in this study are compared with those found in other studies of Spain:
Andalusia (158), Basque country (173), Catalonia (78), Centre Spain (50),
Galicia (103), Valencia (30) [34] and Asturias (126) [35];
and European population [27]
European This study Spain Europe
Haplogroups (N = 686) (N = 718) (N = 2648)
H 323 (47.1) 373 (51.9) 1134 (42.8)
V 34 (5.0) 45 (6.3) 111 (4.2)
HV* 31 (4.5) 8 (1.1) —
J 61 (8.9) 53 (7.4) 260 (9.8)
T 47 (6.9) 40 (5.6) 211 (7.9)
U 155 (22.6) 137 (19.1) 579 (21.9)
I 4 (0.6) 4 (0.6) 59 (2.2)
W 4 (0.6) 14 (1.9) 54 (2.0)
X 8 (1.2) 13 (1.8) 40 (1.5)
O 19 (2.8) 31 (4.3) 200 (7.6)
DISCUSSION
Mitochondrial DNA only encodes proteins involved in the
oxidative phosphorylation (OXPHOS) system and the tRNAs and
rRNAs necessaries to their expression. This system is the common
final pathway in the cell energy production and it is ubiquitous.
Therefore, it is a key component in the cell function. By affecting
energy production, mitochondrial genetic variants might play a role
in the resistance-susceptibility to different phenotypes. As previously
mentioned, more and more diseases are being related to the
mitochondrial genetic background. However, the molecular bases
for these associations are far away to be completely understood yet.
It is still unknown which are the haplogroup or subhaplogroup
defining polymorphisms causing the phenotypic effects.
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TABLE 3. Subhaplogroups U distribution. Number of individuals and percentage
values (in brackets) are given. NE and SE encode for North and South of Europe,
respectively. 8 U5 samples from Spain were not subdivided. Urest from Italy
includes U subhaplogroups belonging to U1811rest (24)
                  Europe
Spain Italy
Subhaplogroup U SE NE
(N =155) (N = 455)
(N = 588) (N =1214)
Urest 21 (13.6) 69 (15.2) 78 (13.3) 52 (4.8)
U4 9 (5.8) 41 (9.0) 59 (10.0) 235 (19.4)
U1811rest 18 (11.6) 72 (15.8) 63 (10.7) 130 (10.7)
Uk 48 (31.0) 154 (33.8) 156 (26.5) 280 (23.1)
U5a 21 (13.6) 72 (15.8) 79 (13.4) 309 (25.5)
U5b 30 (19.4) 47 (10.3) 153 (26.0) 208 (17.1)
A phylogenetic approach to the association studies has the benefit
of being an external criterium. However, and due to the high
mutational rate of the mtDNA, subhaplogroups from different
haplogroups might have similar effects, therefore masking potential
associations. In this sense, the lack of association in LHON patients
with the haplogroup J in the Iranian population (26) has been
recently solved by a finest haplogroup analysis (24). In this
population, the major subhaplogroup J is different from that of the
European population and it is not defined by those polymorphisms
candidate to affect the OXPHOS functionality.
Haplogroups from the HV cluster (H, V and HV*) are more
prevalent in the Spanish population. Haplogroup H originated in the
Near East but its frequency in this region (20-30%) is lower than the
European frequency (40-50%) (27). The Spanish frequency of this
haplogroup is in the upper site of this range (49.6%). However, H
subhaplogroups have highly distinctive geographical distributions
(6, 21-23). The knowledge of these spatial patterns can have
important implications for disease studies. Thus, Spanish families
affected by nonsyndromic sensorineural deafness due to the mtDNA
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1555G mutation in the 12S rRNA gene were overrepresented in the
mitochondrial haplogroup H (28). Two alternatives could explain
this fact. In the first one, the haplogroup might increase the
penetrance of the mutation, similar to the LHON/haplogroup J
phenomenon. In the second alternative, a founder event was
proposed. The analysis of the H subhaplogroups allowed to chose
the second one as the more probable explanation (21).
Haplogroup U has also been associated to different phenotypes
(6, 29-31). Particularly interesting is its association with the MELAS
syndrome. One study showed an excess of individuals from this
haplogroup in patients with MELAS (30). However, another more
extensive study was unable to reproduce this association (32).
Interestingly, the first study was based in patients from northern
Europe and the second one from the south and we have recently
shown significant differences in the U subhaplogroup distribution
in Europe (6). In the north, subhaplogroups U defined by
polymorphisms in very well conserved positions of the cytochrome
b and therefore with a potential phenotypic effect are
overrepresented. It has been hypothesized that these genetic variants
would affect the balance between the energy and heat production
(6, 17, 18). Northern haplogroups would be biased to a higher heat
production but lower energy production efficiency. The contrary
situation would be found in Southern haplogroups. Being this true,
then our results would suggest that the Spanish population, poorer
in U subhaplogroups defined by cytb mutations, would be less
susceptible to develop MELAS syndrome, as observed in one of the
previous studies (32).
The finest characterization of the genetic background from
different populations is a necessary first step to a rational approach
in the epidemiologic association studies as previously proposed in
the Human Genome Diversity Project (33).
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